Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MultiCTR Randomized Double-Blind Double-Dummy Study to Evaluate Clinical Efficacy/Safety of DR 6MP for Targeted Ileal Delivery vs Purinethol in Patients w/Moderately Active Crohn's Disease

NCT01094613 is registered in ClinicalTrials.gov with Teva GTC as lead sponsor.

NCT NCT01094613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01094613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MultiCTR Randomized Double-Blind Double-Dummy Study to Evaluate Clinical Efficacy/Safety of DR 6MP for Targeted Ileal Delivery vs Purinethol in Patients w/Moderately Active Crohn's Disease
Lead sponsor
Teva GTC
Phase
Phase 1/2
Overall status
Terminated
Start date
November 30, 2010
Completion date
December 31, 2012
Enrollment
70 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease